Edwards Lifesciences Legal and insurance accrual decreased by 53.8% to $75.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 171.1%, from $28.00M to $75.90M. Over 5 years (FY 2020 to FY 2025), Legal and insurance accrual shows an upward trend with a 47.8% CAGR.
other_accrued_litigation_and_insurance_reserves| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $75.80M | $77.40M | $79.10M | $78.30M | $83.20M | $81.10M | $28.10M | $29.10M | $30.40M | $30.30M | $30.70M | $32.90M | $32.50M | $29.50M | $26.80M | $28.00M | $26.40M | $104.90M | $164.20M | $75.90M |
| QoQ Change | — | +2.1% | +2.2% | -1.0% | +6.3% | -2.5% | -65.4% | +3.6% | +4.5% | -0.3% | +1.3% | +7.2% | -1.2% | -9.2% | -9.2% | +4.5% | -5.7% | +297.3% | +56.5% | -53.8% |
| YoY Change | — | — | — | — | +9.8% | +4.8% | -64.5% | -62.8% | -63.5% | -62.6% | +9.3% | +13.1% | +6.9% | -2.6% | -12.7% | -14.9% | -18.8% | +255.6% | +512.7% | +171.1% |